Pàgina inicial > Resultats de la cerca: Syrigos, K.
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 3 registres trobats en 0.02 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
6 p, 380.2 KB Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer : final results of a randomised phase 2 clinical trial / Gridelli, C. (S.G. Moscati Hospital) ; Ciuleanu, Tudor Eliade (Institutui. Oncologic I. Chircuta) ; Domine, M. (Fundacion Jimenez Diaz) ; Szczesna, A. (Mazowieckie Centrum) ; Bover, I. (Hospital Universitari Son Llàtzer (Palma de Mallorca, Balears)) ; Cobo, M. (Instituto de Investigaciones Biomédicas (IBIMA)) ; Kentepozidis, N. (251 General Airforce Hospital) ; Zarogoulidis, K. (Papanikolaou General Hospital) ; Kalofonos, C. (University Hospital of Patras) ; Kazarnowisz, A. (Oddzial Onkologiiz Pododdziatem) ; Korozan, M. (Hospicjum Dutkiewicza SAC) ; de las Peñas, R (Hospital Provincial de Castellon) ; Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau) ; Chella, A. (A.O.U. di Pisa Hospital) ; Griesinger, F. (Pius Hospital) ; Bournakis, E. (University Hospital "Aretaieion") ; Sadjadian, P. (Johannes Wesling Klinikum) ; Kotsakis, A. (University General Hospital of Larissa) ; Chinet, T. (Hopital Ambroise Paré) ; Syrigos, K.N. (General Hospital of Thoracic Diseases "Sotiria") ; Correale, P. (University Hospital of Siena) ; Gallou, C. (Vaxon-Biotech) ; Jamet, J.M. (Vaxon-Biotech) ; Vetsika, E.K. (University General Hospital of Heraklion) ; Kosmatopoulos, K. (Vaxon-Biotech) ; Georgoulias, V. (University General Hospital of Heraklion) ; Universitat Autònoma de Barcelona
The cancer vaccine Vx-001, which targets the universal tumour antigen TElomerase Reverse Transcriptase (TERT), can mount specific Vx-001/TERT CD8 + cytotoxic T cells; this immune response is associated with improved overall survival (OS) in patients with advanced/metastatic non-small cell lung cancer (NSCLC). [...]
2020 - 10.1038/s41416-020-0785-y
British Journal of Cancer, Vol. 122 Núm. 10 (december 2020) , p. 1461-1466  
Registre complet - Creative Commons
2.
11 p, 362.8 KB Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism : Rationale and Design of the API-CAT Study / Mahé, Isabelle (Université de Paris (França)) ; Agnelli, Giancarlo (University of Perugia) ; Ay, Cihan (Medical University of Vienna) ; Bamias, Aristotelis (National & Kapodistrian University of Athens) ; Becattini, Cecilia (University of Perugia) ; Carrier, Marc (Department of Medicine, University of Ottawa) ; Chapelle, Céline (Université Jean Monnet) ; Cohen, Alexander T. (King's College London) ; Girard, Philippe (Département de Pneumologie, Institut Mutualiste Montsouris) ; Huisman, Menno V. (Department of Medicine − Thrombosis and Hemostasis, Leiden University Medical Center) ; Klok, Frederikus A. (Department of Medicine − Thrombosis and Hemostasis, Leiden University Medical Center) ; López Núñez, Juan José (Universitat Autònoma de Barcelona. Departament de Medicina) ; Maraveyas, Anthony (Hull University Teaching Hospitals NHS Trust (Regne Unit)) ; Mayeur, Didier (Centre Georges-Francois Leclerc (França)) ; Mir, Olivier (Institut Gustave-Roussy (França)) ; Monreal, Manuel (Universidad Católica San Antonio de Murcia) ; Righini, Marc (Geneva University Hospitals) ; Samama, Charles M. (Department of Anaesthesia, Hôpital Cochin (França)) ; Syrigos, Kostas (Department of Medicine, National & Kapodistrian University) ; Szmit, Sebastian (Departments of Pulmonary Circulation, Thromboembolic Diseases, and Cardiology, Centre of Postgraduate Medical Education, European Health Centre (Polònia)) ; Torbicki, Adam (Departments of Pulmonary Circulation, Thromboembolic Diseases, and Cardiology, Centre of Postgraduate Medical Education, European Health Centre (Polònia)) ; Verhamme, Peter (University Hospitals Leuven (Bèlgica)) ; Vicaut, Eric (Université de Paris) ; Wang, Tzu-Fei (Department of Medicine, University of Ottawa) ; Meyer, Guy (Sorbonne Paris Cité) ; Laporte, Silvy (Université Jean Monnet)
Cancer-associated thrombosis (CT) is associated with a high risk of recurrent venous thromboembolic (VTE) events that require extended anticoagulation in patients with active cancer, putting them at risk of bleeding. [...]
2021 - 10.1055/a-1647-9896
Thrombosis and Haemostasis, Vol. 122 (september 2021) , p. 646-656  
Registre complet - Creative Commons
3.
12 p, 339.3 KB Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC : Results From the Phase 3 TAHOE Study / Blackhall, Fiona (Department of Medical Oncology. The Christie National Health Service (NHS) Foundation Trust) ; Jao, K. (Department of Hematology and Oncology. Hopital du Sacre Coeur Montreal) ; Greillier, L. (Multidisciplinary Oncology and Therapeutic Innovations Department. Centre de Recherche en Cancérologie de Marseille (CRCM). Centre National de la Recherche Scientifique (CNRS). Institut National de la Santé et de la Recherche Médicale (INSERM). Assistance Publique-Hopitaux de Marseille (APHM). Aix-Marseille University) ; Cho, B.C. (Division of Medical Oncology. Department of Internal Medicine. Yonsei Cancer Center. Yonsei University College of Medicine) ; Penkov, K. (Private Medical Institution Euromedservice) ; Reguart, Noemi (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau) ; Nackaerts, K. (Department of Pulmonology and Respiratory Oncology. University Hospital Leuven. Katholieke Universiteit (KU) Leuven) ; Syrigos, K. (Department of Medicine. National and Kapodistrian University of Athens) ; Hansen, K. (Odense University Hospital (Dinamarca)) ; Schuette, W. (2nd Medical Department. Krankenhaus Martha-Maria Halle-Doelau. Halle) ; Cetnar, J. (Department of Medicine. Oregon Health & Science University) ; Cappuzzo, F. (Department of Medical Oncology. Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)) ; Okamoto, I. (Department of Medical Oncology. Kyushu University Hospital) ; Erman, M. (Department of Medical Oncology. Cancer Institute. Hacettepe University) ; Langer, S.W. (Rigshospitalet. University of Copenhagen) ; Kato, T. (Department of Thoracic Oncology. Kanagawa Cancer Center) ; Groen, H. (Department of Pulmonary Disease. University Medical Center Groningen. University of Groningen) ; Sun, Z. (AbbVie. Inc.) ; Luo, Y. (AbbVie. Inc.) ; Tanwani, P. (AbbVie. Inc.) ; Caffrey, L. (AbbVie. Inc.) ; Komarnitsky, P. (AbbVie. Inc.) ; Reinmuth, N. (Thoracic Oncology Department. Asklepios Fachkliniken München-Gauting)
Introduction: DLL3, an atypical Notch ligand, is expressed in SCLC tumors but is not detectable in normal adult tissues. Rovalpituzumab tesirine (Rova-T) is an antibody-drug conjugate containing a DLL3-targeting antibody tethered to a cytotoxic agent pyrrolobenzodiazepine by means of a protease-cleavable linker. [...]
2021 - 10.1016/j.jtho.2021.02.009
Journal of Thoracic Oncology, Vol. 16 Núm. 9 (september 2021) , p. 1547-1558  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
1 Syrigos, K.N.
1 Syrigos, Kostas
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem